2558 Impact of PTEN protein loss on response to docetaxel and overall survival (OS) in metastatic castration resistant prostate cancer (mCRPC) patients. (September 2015) - Rescigno, P.; Lorente, D.; Bianchini, D.; Kolinsky, M.; Zafeiriou, Z.; Ferraldeschi, R.; Mateo, J.; Recine, F.; Jayaram, A.; Nava Rodrigues, D.; Riisnaes, R.; Miranda, S.; et al.